Related Experiment Video
Updated: Sep 1, 2025
10:19
Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models
Published on: August 9, 2012
19.4K
Pediatric Bladder Tumors: A Ten-Year Retrospective Analysis
Andrew D Shumaker1, Miriam Harel1, Jordan Gitlin1
1Pediatric Urology Associates, P.C. Tarrytown, NY.
Urology
|August 15, 2022
Summary
This study reviewed 30 pediatric bladder tumors over 10 years, finding a mix of inflammatory and malignant types. Fortunately, most patients achieved no evidence of disease after treatment, highlighting the importance of understanding pediatric bladder tumor management.
Area of Science:
- Pediatric Urology
- Oncology
- Medical Research
Background:
- Pediatric bladder tumors are rare, with limited existing data on their presentation, management, and natural history.
- Understanding the spectrum of these tumors is crucial for effective clinical care.
Purpose of the Study:
- To present a single pediatric urology practice's 10-year experience with bladder tumors in children.
- To expand knowledge on the presentations, management strategies, and natural history of pediatric bladder tumors.
Main Methods:
- Retrospective review of electronic medical records from 2011 to 2021.
- Inclusion criteria focused on bladder tumors, excluding patients with pre-existing bladder conditions.
- Utilized International Classification of Diseases, Tenth Revision (ICD-10) and Current Procedural Terminology (CPT) codes for patient identification.
Main Results:
- Thirty pediatric bladder tumors were identified in patients aged 16 months to 19 years.
- Tumor types included inflammatory subtypes (11), papillomas (4), rhabdomyosarcomas (4), papillary urothelial neoplasms of low malignant potential (3), and others (8).
- All 30 patients achieved no evidence of disease at the most recent follow-up, with a median follow-up of 19 months.
Conclusions:
- Pediatric bladder tumors encompass a range from aggressive rhabdomyosarcomas to more common benign urothelial lesions.
- The majority of identified tumors were of less aggressive subtypes.
- Knowledge of treatment options and natural history benefits clinicians and parents.
